Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).
Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).
复制标题
噻唑呋林及其硒类似物(2-β-D-呋喃核糖基-4-硒唑甲酰胺)的生化和抗肿瘤活性。
DOI:
10.1016/0006-2952(85)90617-3
复制
发表时间:
1985
影响因子:
5.8
通讯作者:
R. Jackson
中科院分区:
文献类型:
--
作者:
T. Boritzki;D. Berry;J. Besserer;P. D. Cook;D. W. Fry;W. Leopold;R. Jackson
2-β-D-Ribofuranosyl-4-selenazolecarboxamide (selenazofurin, CI-935), the selenium analog of tiazofurin (CI-909), was 3- to 10-fold more cytotoxic to murine or human tumor cellsin vitrothan tiazofurin and was also more active against P388 mouse leukemiain vivo.In vitrocytotoxicity could be reversed by guanosine or guanine but not by other purine nucleosides or bases. Three human tumor cell lines selected for selenazofurin or tiazofurin resistance showed crossresistance between selenazofurin and tiazofurin. Treatment with tiazofurin, selenazofurin, or mycophenolic acid decreased guanylate pools and caused an accumulation of IMP in WIL2 human lymphoma cells. The decrease in guanylate pools was accompanied by inhibition of RNA and DNA synthesis. The NAD analogs of tiazofurin and selenazofurin were inhibitors of L1210 IMP dehydrogenase (IMP:NAD oxidoreductase, EC 1.2.1.14), and both showed uncompetitive inhibition with respect to NAD havingKiivalues of 5.7 × 10−8M and 3.3 × 10−8M respectively.
影响因子:
11.2
作者:
Cohen,MB;Sadee,W
通讯作者:
Sadee,W
DOI:
10.1016/s0006-291x(83)80179-x
发表时间:
1983
影响因子:
3.1
作者:
Streeter,DG;Robins,RK
通讯作者:
Robins,RK